Oxford Biomedica to acquire 80% stake in AAV Manufacturing and Innovation Business
LONDON, UK: Oxford Biomedica has entered into an agreement with Homology Medicines Inc. to acquire an 80 per cent ownership interest in a newly formed AAV focused manufacturing and innovation business, Oxford Biomedica Solutions LLC or Oxford Biomedica Solutions’ AAV…